|
SERAC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.54329999999936E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.64448999999678E-05 |
| Normal-vs-Stage2 |
7.670100E-02 |
| Normal-vs-Stage3 |
2.896800E-01 |
| Normal-vs-Stage4 |
7.073800E-02 |
| Stage1-vs-Stage2 |
4.742600E-01 |
| Stage1-vs-Stage3 |
2.570200E-01 |
| Stage1-vs-Stage4 |
9.560200E-01 |
| Stage2-vs-Stage3 |
6.819400E-01 |
| Stage2-vs-Stage4 |
6.287800E-01 |
| Stage3-vs-Stage4 |
4.776000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.60034999999725E-05 |
| Normal-vs-AfricanAmerican |
9.484100E-02 |
| Normal-vs-Asian |
1.172440E-01 |
| Caucasian-vs-AfricanAmerican |
2.079800E-01 |
| Caucasian-vs-Asian |
7.164000E-01 |
| AfricanAmerican-vs-Asian |
8.759600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.83820000010782E-07 |
| Normal-vs-Female |
3.697200E-01 |
| Male-vs-Female |
7.479700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.012300E-02 |
| Normal-vs-Extreme_Weight |
1.5321000002011E-07 |
| Normal-vs-Obese |
1.302620E-03 |
| Normal-vs-Extreme_Obese |
1.033680E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.025400E-01 |
| Normal_Weight-vs-Obese |
7.927000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.286800E-01 |
| Extreme_Weight-vs-Obese |
7.019800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.655800E-01 |
| Obese-vs-Extreme_Obese |
7.194000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.871200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.659200E-03 |
| Normal-vs-Age(61-80Yrs) |
1.34849999999798E-06 |
| Normal-vs-Age(81-100Yrs) |
2.30569999981611E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.864000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.279850E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.693800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.105600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.589800E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.616360E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.13460000003862E-06 |
| Normal-VS-Type2 PRCC |
5.736700E-03 |
| Normal-VS-KIRP CIMP |
4.826000E-01 |
| Normal-VS-Unclassified PRCC |
2.543800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.324400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.014400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.396000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.034200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.853600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.670200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.032250E-02 |
| Normal-vs-N1 |
6.237000E-01 |
| Normal-vs-N2 |
1.754500E-02 |
| N0-vs-N1 |
2.291600E-01 |
| N0-vs-N2 |
7.315800E-01 |
| N1-vs-N2 |
3.893200E-01 |
|
|
